Private insurers say they need more evidence that the treatment actually slows the rate at which Alzheimer's patients deteriorate.

Centene has agreed to pay more than $200 million to resolve claims in four states and expects more to come.

Bright Heath's market debut caps a string of public listings of new health care businesses, including insurers and primary-care companies.

New York has revived a bill that would impose stricter oversight on pharmacy benefit managers, but will it be pre-empted by ERISA?

Procedures analyzed in the study included joint replacements, spinal fusions and bariatric surgeries.

Employers are growing increasingly uneasy about their share of the treatment costs for rising numbers of patients with COVID.

For drugmakers, the pandemic has squeezed demand for everything from childhood vaccines to smoking-cessation drugs.

A new guidebook identifies 49 drugs with less expensive alternatives that could be cut from the lists of drugs covered by employers.